1- (1- phenylcyclohexyl)- 3- methylpiperidine (PCMP)

01/01/2023 - "Two out of 5 wounds healed by week 4. The mean percentage area reduction of all wounds was 59.7% by week 4 and 78.1% by week 6. All wounds were fluorescence positive on week 1 and fluorescence negative by Week 4. PCMP, as an antimicrobial barrier, combined with use of a real-time method of bacterial detection, may be beneficial in managing the wound healing environment."
03/01/2018 - "The remaining 3 wounds demonstrated improved wound appearance with 100% granulation tissue and an average area reduction during PCMP treatment of 61.4%. "
01/01/2023 - "This study determined the effectiveness of a wound scaffold comprised of PCMP for use in nonhealing, cutaneous wounds; this study analyzes pooled data from the population of 3 combined registries. "
01/01/2022 - "The RESPOND study demonstrated that PCMP has clinically meaningful benefits in managing a variety of wounds. "
01/01/2023 - "This 434-patient PCMP cohort analysis showed 72% wound closure and median time to wound closure of 19 weeks. "

01/01/2012 - "PCMP compared with idiopathic cardiomyopathy is characterized by less pronounced dilation of left cardiac chambers, relative preservation of left ventricular contractile function, more favorable course of CHF with lower frequency of destabilizations of clinical state. "
01/01/2011 - "These data confirm the advisability of regarding PCMP as a separate nosological entity in the group of seconfary cardiomyopathies."
01/01/2012 - "Results of the study of special characteristics of the course of chronic heart failure (CHF) in women with periportal cardiomyopathy (PCMP) are presented. "
01/01/2009 - "It is concluded that phenothiazine-induced dilatation cardiomyopathy should be regarded as a separate nosological form belonging to a group of secondary DCMPs and designated as PCMP."
01/01/2009 - "65 cases of PCMP (46 in men and 19 in women) were revealed at postmortem examination (2% of all autopsies or significantly higher than the general incidence of idiopathic dilatation cardiomyopathies (DCMP). "

01/01/2012 - "Results of the study of special characteristics of the course of chronic heart failure (CHF) in women with periportal cardiomyopathy (PCMP) are presented. "

01/01/2012 - "PCMP has developed mainly during postportal period and in women with preexisting anemia and chronic viral diseases."

01/01/2009 - "Analysis of the patients" medical histories, dynamics of clinical conditions, and results of electrocardiography did not show significant differences between patients with schizophrenia and PCMP compared with mentally healthy DCPM subjects DCMP. "
01/01/2009 - "The author considers selected clinical and morphological characteristics of secondary dilatation cardiomyopathy in patients with schizophrenia after long-term treatment with phenotiazine neuroleptics for the purpose of substantiating nosological self-sufficiency of this pathology (PCMP). "